Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Completed · Phase 3 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of this study is to determine if abatacept is effective in the treatment of early rheumatoid arthritis.

Key facts

Study ID
NCT02504268
Run by
Bristol-Myers Squibb
People needed
994
Starts
2015-09-03
Expected to finish
2020-03-19
Last updated by the study team
2021-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.